Buy Durataf 25mg Tablet Online
About Durataf 25mg Tablet
Salt : Tenofovir Alafenamide (25mg)
Product Introduction
Durataf 25mg Tablet is used in the treatment of HIV infection and chronic hepatitis B virus (HBV) infection. It prevents the multiplication of viruses in human cells. This stops the virus from producing new viruses and clears up your infection.
Durataf 25mg Tablet should be used in the dose and duration as advised by your doctor. Do not skip any doses and finish the full course of treatment even if you feel better. Take it with food, as this increases the absorption of the medicine into the body. It is important to keep taking them until your doctor tells you it is safe to stop.
Common side effects of this medicine include headache, diarrhea, nausea, joint pain, abdominal pain, and indigestion. Please consult your doctor if it persists for a longer duration. These are usually not serious but tell your doctor if they bother you or do not go away. Rarely, some people may experience a skin reaction or liver damage. Your doctor will closely monitor you for these in the initial period of treatment.
Before taking it, tell your doctor if you have any skin problems or liver or kidney disease. While using it, you may need regular blood tests to check your blood counts and liver function. Avoid drinking alcohol as it may increase your risk of liver damage. Pregnant or breastfeeding mothers should consult their doctor before using this medicine. Do not have unprotected sex or share personal items like razors or toothbrushes, if you are HIV positive. Talk to your doctor about safe ways like condoms to prevent HIV transmission during sex.
Uses of Durataf Tablet
- Treatment of Chronic hepatitis B virus (HBV) infection
Benefits of Durataf Tablet
In Treatment of Chronic hepatitis B virus (HBV) infection
Side effects of Durataf Tablet
Common side effects of Durataf
- Headache
- Diarrhea
- Nausea
- Fatigue
- Abdominal pain
- Cough
- Back pain
- Indigestion
- Joint pain
How to use Durataf Tablet
How Durataf Tablet works
Safety Advices
Pregnancy
Durataf 25mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast Feeding
Durataf 25mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Lungs
Durataf 25mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Durataf 25mg Tablet may be needed. Please consult your doctor.
Liver
Durataf 25mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Durataf 25mg Tablet may not be needed in these patients. Please consult your doctor.
Alcohol
It is not known whether it is safe to consume alcohol with Durataf 25mg Tablet. Please consult your doctor.
Driving
Durataf 25mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
What if you forget to take Durataf Tablet?
Quick tips
- You have been prescribed Durataf 25mg Tablet for the treatment of chronic hepatitis B virus (HBV) infection.
- In combination with other medicines, it is used for the treatment of HIV infections.
- Take it with food, as this increases the absorption of the medicine into the body.
- Durataf 25mg Tablet may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
- You may still develop infections or other illnesses associated with viral infection while taking this medication.
- You can also pass on HIV or HBV to others. Don’t share needles or personal items that can have blood or body fluids on them.
- During treatment and for at least six months after stopping this medicine, regular blood tests are needed to monitor your liver function, level of hepatitis B virus and blood cells in your blood.
Side Effects of Durataf 25mg Tablet
Durataf 25mg Tablet causes some side effects like all medications, although not everyone will experience them.
Serious:
- Too much lactic acid in the blood (unusual weakness, muscle pain, cold hands and feet)
- Severe liver problems (yellow skin and eyes, tea-colored urine, light-colored stools, loss of appetite)
- Severe kidney problems
Common:
- Nausea, vomiting
- Diarrhea
- Stomach pain, joint pain
- Rash, itching
- Feeling tired
- Headache, dizziness
Word of Advice
If you are considering taking Durataf 25mg Tablet, it is important to be aware of the potential risks and warnings associated with this medication. Pregnancy and breastfeeding require individual evaluation and consultation with a healthcare provider to weigh the benefits against potential risks. It should be used cautiously in individuals with pre-existing conditions such as liver disease, kidney disease, or bone disorders, as it may exacerbate them. Close monitoring and appropriate management are necessary in these cases. Adherence to these precautions and regular monitoring and communication with the healthcare provider can help ensure safe and effective use.
FAQs
Q 1. Can Tablet be taken with other antiretroviral medications?
Yes, Durataf 25mg Tablet is often combined with other antiretroviral medications as part of a multidrug regimen for treating HIV infection. The specific combination of medications will depend on individual health status, treatment history, and potential drug interactions.
Q 2. Can Tablet be safely used in older adults?
Durataf 25mg Tablet can be used in older adults, but dosage adjustments or additional monitoring may be necessary, as age-related changes in kidney and liver function can affect medication clearance. It is important to discuss individual health status and any concerns with a healthcare provider.
Q 3. Can Tablet cause weight gain?
Weight gain is not a commonly reported side effect of Durataf 25mg Tablet. However, individual responses to medications can vary, and some people may experience changes in weight while taking this medication. It is important to discuss any concerns about weight changes with your healthcare provider.
Q 4. Can Durataf 25mg Tablet be used during chemotherapy or radiation therapy?
The use of Durataf 25mg Tablet in individuals undergoing chemotherapy or radiation therapy should be evaluated on a case-by-case basis, considering potential drug interactions and individual health factors. It is crucial to consult the HIV specialist and oncologist to determine the most appropriate treatment approach.
Q 5. Can Durataf 25mg Tablet be taken during surgery or dental procedures?
If you are scheduled for surgery or dental procedures, informing your healthcare provider or dentist about your Durataf 25mg Tablet treatment is important. They can guide whether any adjustments need to be made, such as temporary discontinuation or use of other medications during the procedure.
Q 6. Can Durataf 25mg Tablet cause lactic acidosis?
Although rare, Durataf 25mg Tablet has been associated with the risk of lactic acidosis. Lactic acidosis is a serious condition characterized by the buildup of lactic acid in the blood. It is important to promptly report any symptoms such as unusual weakness, rapid breathing, nausea, vomiting, abdominal pain, or unexplained muscle pain to your healthcare provider while taking it.
Fact Box of Durataf 25mg Tablet
| Molecule name:Â Tenofovir alafenamide | Therapeutic class:Â Antiviral agents |
| Pharmacological class:Â Nucleoside reverse transcriptase inhibitors (NRTIs) | Indications:
1. HIV- 1 Infection 2. Hepatitis B infection |
References
- KD Tripathi, Essentials of Medical Pharmacology, Antiviral drugs, 7th edition, 2013, 808.
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Antiviral agents (Non-retroviral), 12th edition, 2011, 1615.
- Gilead Sciences Ltd, Electronic medicines compendium (EMC), [ Revised on Jan 2021] [ Accessed on 18th May 2023], https://www.medicines.org.uk/emc/files/pil.2314.pdf
- Gilead Sciences, US Food, and Drug Administration, [ Revised on Feb 2020] [ Accessed on 18th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208464s008lbl.pdf
